UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 29, 2020
Accession Number:
0001193125-20-255644
Submission Type:
POS AM
CIK:
0001510487
Company Name:
Principia Biopharma Inc.
File Number:
333-234038